Melphalan Hydrochloride NDC 67457-195

NDC codes

FDA NDC Directory

Product NDC (as listed)67457-195Labeler and product segments. Claims need a package NDC.

Product NDC at billing width67457-0195Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
67457-195-01	67457019501	1 KIT in 1 CARTON (67457-195-01) * 10 mL in 1 VIAL, GLASS (67457-193-50) * 10 mL in 1 VIAL, GLASS (67457-194-10)Marketed from Jan 10, 2013

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Melphalan Hydrochloride
Generic name (nonproprietary): melphalan hydrochloride
Dosage form: Kit
Labeler: Mylan Institutional LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 090270
Marketing start: Jan 10, 2013
Listing expires: Dec 31, 2026
Identifiers: Product ID 67457-195_14d237c9-0b9f-4101-ae53-c6ffe9928801SPL ID 14d237c9-0b9f-4101-ae53-c6ffe9928801SPL set ID a8bf1877-fd06-4ef6-b82d-fe0ff1956bdeRxCUI 311487

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N467457019501 followed by a unit qualifier and the quantity

Package 67457-0195-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Sep 16, 2020. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE Melphalan Hydrochloride for Injection is indicated for the palliative treatment of patients with multiple myeloma for whom oral therapy is not appropriate.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)